Dedicated to Finding New Medicines Through Targeting the Ubiquitin Pathway

News Headlines

Progenra collaborates with Children’s Hospital of Philadelphia on novel immune-oncology drug

Findings published in eBioMedicine

Learn More >


Upcoming Meetings

Progenra is invited to speak at Cambridge Healthtech Institute’s Small Molecules for Cancer Immunotherapy symposium as part of the Twelfth Annual Drug Discovery Chemistry event.

Progenra to speak at 18th Annual  Drug Discovery Leaders’ Summit alongside our Discovery Chemistry and Drug Design Congress in June 2017 in Berlin.

Learn More >


Business Development

Progenra is seeking industry partnerships for licensing opportunities surrounding the company’s small molecule portfolio Drug Discovery Platform


Learn More >